Magali Rouquette

Title: Magali Rouquette: Innovator in Neurodegenerative Pathologies

Introduction

Magali Rouquette is a prominent inventor based in Toulouse, France. She has made significant contributions to the fields of biology, genetics, and medicine. Her work focuses on developing novel methods for the detection and treatment of neurodegenerative pathologies.

Latest Patents

Magali Rouquette holds a patent titled "Methods involving PDE4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologies." This invention relates to innovative methods for detecting, characterizing, and managing neurodegenerative pathologies. It also includes methods for identifying or screening compounds that are active in these disorders. The invention is based on the identification of the role of phosphodiesterase 4B, the peripheral benzodiazepine receptor (PBR), and GABA receptors of the type GABA(A) in neurodegenerative conditions. These findings describe the use of these elements as therapeutic, diagnostic, or experimental markers for such disorders. Magali Rouquette has 1 patent to her name.

Career Highlights

Magali is currently associated with Exonhit Therapeutics, a company dedicated to advancing therapeutic solutions in the medical field. Her work at Exonhit Therapeutics has positioned her as a key player in the research and development of treatments for complex medical conditions.

Collaborations

Magali collaborates with notable colleagues, including Annelies Resink and Laurent Desire. These partnerships enhance her research efforts and contribute to the advancement of innovative solutions in her field.

Conclusion

Magali Rouquette is a trailblazer in the realm of neurodegenerative pathologies, with her innovative patent and collaborative efforts paving the way for future advancements in medical treatments. Her contributions are vital to the ongoing research in this critical area of health.